Therapeutically blocking interleukin-11 receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours

Amy Winship(Monash University), Evdokia Dimitriadis(Monash University)
Oncotarget
February 8, 2017
Cited by 26


Related Papers